Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
Posted On Wednesday, June 11, 2025
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG
Posted On Wednesday, June 11, 2025
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
Posted On Wednesday, June 11, 2025
Cabaletta Bio Announces Pricing of Public Offering of Securities
Posted On Wednesday, June 11, 2025
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
Posted On Wednesday, June 11, 2025
Moleculin Participates in Virtual Investor “What This Means” Segment
Posted On Wednesday, June 11, 2025
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
Posted On Wednesday, June 11, 2025
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
Posted On Wednesday, June 11, 2025
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
Posted On Wednesday, June 11, 2025
Artelo Biosciences Announces Reverse Stock Split
Posted On Wednesday, June 11, 2025
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Posted On Wednesday, June 11, 2025
Veru to Participate in the Virtual BTIG Obesity Health Forum
Posted On Wednesday, June 11, 2025
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
Posted On Wednesday, June 11, 2025
OKYO Pharma to Present at the Bio International Convention
Posted On Wednesday, June 11, 2025
Lisata Therapeutics to Present at the 2025 BIO International Convention
Posted On Wednesday, June 11, 2025
Ocugen To Present at BIO International Convention 2025
Posted On Wednesday, June 11, 2025
Cabaletta Bio Announces Proposed Public Offering of Securities
Posted On Wednesday, June 11, 2025
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
Posted On Wednesday, June 11, 2025
Basecamp Research Announces Breakthrough Discovery of Over One Million New Species, Yielding Enormous New Database Purpose-Built for Generative Foundation Models in Biology
Posted On Wednesday, June 11, 2025
Persica strengthens global IP portfolio with EU patent granted for PP353
Posted On Wednesday, June 11, 2025
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
Posted On Tuesday, June 10, 2025
BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)
Posted On Tuesday, June 10, 2025
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
Posted On Tuesday, June 10, 2025
Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors
Posted On Tuesday, June 10, 2025
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, June 10, 2025

Print